Literature DB >> 15253964

Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention.

C Mueller1, F-J Neumann, A P Perruchoud, H J Buettner.   

Abstract

OBJECTIVES: To quantify the impact of baseline renal function on in-hospital and long term mortality in patients with unstable angina/non-ST elevation acute myocardial infarction (UA/NSTEMI) treated with a very early invasive strategy.
DESIGN: Prospective cohort study of 1400 consecutive patients with UA/NSTEMI undergoing coronary angiography and subsequent coronary stenting of the culprit lesion as the primary revascularisation strategy within 24 hours of admission. Patients were stratified according to calculated glomerular filtration rate (GFR) on admission.
RESULTS: In-hospital mortality was 0% among patients with a GFR > or = 130 ml/min/1.73 m2, 0.4% with a GFR of 90-129 ml/min/1.73 m2, 2.6% with a GFR of 60-89 ml/min/1.73m2, and 5.1% with a GFR of < 60 ml/min/1.73 m2. Cumulative three year survival rates were 92.6%, 95.5%, 91.9%, and 76.8%, respectively. Patients with a GFR of < 60 ml/min/1.73 m2 were four times more likely to die in hospital (hazard ratio (HR) 4.0, 95% confidence interval (CI) 1.8 to 9.1; p = 0.001) and four times more likely to die during long term follow up (HR 4.0, 95% CI 2.5 to 6.4; p < 0.001). After adjusting for potential confounders, a GFR of < 60 ml/min/1.73 m2 remained a strong independent predictor of long term mortality (HR 2.6, 95% CI 1.5 to 4.5; p = 0.001).
CONCLUSIONS: Baseline renal function is a strong independent predictor of in-hospital and long term mortality after UA/NSTEMI treated with very early revascularisation.

Entities:  

Mesh:

Year:  2004        PMID: 15253964      PMCID: PMC1768394          DOI: 10.1136/hrt.2003.021741

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Risks associated with renal dysfunction in patients in the coronary care unit.

Authors:  P A McCullough; S S Soman; S S Shah; S T Smith; K R Marks; J Yee; S Borzak
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

Review 4.  Renal function: the Cinderella of cardiovascular risk profile.

Authors:  L M Ruilope; D J van Veldhuisen; E Ritz; T F Luscher
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

5.  Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure.

Authors:  Luis Gruberg; George Dangas; Roxana Mehran; Gary S Mintz; Kenneth M Kent; Augusto D Pichard; Lowell F Satler; Alexandra J Lansky; Gregg W Stone; Martin B Leon
Journal:  Catheter Cardiovasc Interv       Date:  2002-01       Impact factor: 2.692

6.  Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study.

Authors:  R Spacek; P Widimský; Z Straka; E Jiresová; J Dvorák; R Polásek; I Karel; R Jirmár; L Lisa; T Budesínský; F Málek; P Stanka
Journal:  Eur Heart J       Date:  2002-02       Impact factor: 29.983

7.  Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.

Authors:  L A Szczech; P J Best; E Crowley; M M Brooks; P B Berger; V Bittner; B J Gersh; R Jones; R M Califf; H H Ting; P J Whitlow; K M Detre; D Holmes
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

8.  The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.

Authors:  Patricia J M Best; Ryan Lennon; Henry H Ting; Malcolm R Bell; Charanjit S Rihal; David R Holmes; Peter B Berger
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

9.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

10.  Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction.

Authors:  J N Beattie; S S Soman; K R Sandberg; J Yee; S Borzak; M Garg; P A McCullough
Journal:  Am J Kidney Dis       Date:  2001-06       Impact factor: 8.860

View more
  7 in total

Review 1.  Chronic kidney disease in acute coronary syndromes.

Authors:  Giancarlo Marenzi; Angelo Cabiati; Emilio Assanelli
Journal:  World J Nephrol       Date:  2012-10-06

2.  Cost effectiveness of fondaparinux in non-ST-elevation acute coronary syndrome.

Authors:  Jaime Latour-Perez; Eva de-Miguel-Balsa
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study.

Authors:  Maria Udeanu; Giordano Guizzardi; Giuseppe Di Pasquale; Antonio Marchetti; Francesca Romani; Vittorio Dalmastri; Irene Capelli; Lucia Stalteri; Giuseppe Cianciolo; Paola Rucci; Gaetano La Manna
Journal:  BMC Nephrol       Date:  2014-09-17       Impact factor: 2.388

Review 4.  Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins.

Authors:  K M Eggers; B Lindahl
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

5.  Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management.

Authors:  Subir Bhatia; Shilpkumar Arora; Sravya M Bhatia; Mohammed Al-Hijji; Yogesh N V Reddy; Parshva Patel; Charanjit S Rihal; Bernard J Gersh; Abhishek Deshmukh
Journal:  J Am Heart Assoc       Date:  2018-03-10       Impact factor: 5.501

Review 6.  A critical review of chronic kidney disease as a risk factor for coronary artery disease.

Authors:  Mark Coyle; Gerard Flaherty; Catriona Jennings
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-15

7.  Impact of electrocardiographic morphology on clinical outcomes in patients with non-ST elevation myocardial infarction receiving coronary angiography and intervention: a retrospective study.

Authors:  Chiung-Jen Wu; Kuo-Ho Yeh; Hui-Ting Wang; Wen-Hao Liu; Huang-Chung Chen; Han-Tan Chai; Wen-Jung Chung; Shukai Hsueh; Chien-Jen Chen; Hsiu-Yu Fang; Yung-Lung Chen
Journal:  PeerJ       Date:  2020-05-07       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.